Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

NCT00046137 Phase 3 COMPLETED

The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.

Details

Lead sponsor	Eli Lilly and Company
Phase	Phase 3
Status	COMPLETED

Conditions

• Osteoporosis, Postmenopausal

Interventions

• teriparatide
• raloxifene
• placebo

Countries

United States